NCT07518186
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT07518186
Title A Study Comparing JNJ-79635322 and Teclistamab in Participants With Relapsed or Refractory Multiple Myeloma (TRIlogy-5)
Acronym TRIlogy-5
Recruitment Recruiting
Gender both
Phase Phase III
Variant Requirements No
Sponsors Janssen Research & Development, LLC
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA | TUR | ISR

Facility Status City State Zip Country Details
Highlands Oncology Group RECRUITING Springdale Arkansas 72762 United States Details
Nebraska Cancer Specialists RECRUITING Omaha Nebraska 68130 United States Details
Rambam Med.Center - Hematology Institute RECRUITING Haifa 3109601 Israel Details
Carmel Medical Center RECRUITING Haifa 3436212 Israel Details
China Medical University Hospital RECRUITING Taichung 40447 Taiwan Details
Taichung Veterans General Hospital RECRUITING Taichung 40705 Taiwan Details
Taipei Veterans General Hospital RECRUITING Taipei 112 Taiwan Details
Medipol Mega University Hospital RECRUITING Istanbul 34214 Turkey (Türkiye) Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field